Arch Life Sciences Limited - pharma in Hyderabad, Telangana, India. FY 2026 financials & compliance.
CIN U24239TG2003PLC042232 Incorporated 15 December 2003 ROC Hyderabad HQ Hyderabad, Telangana, India
Active Public Limited Company pharma
Revenue · FY 2024
₹10,510
▲ 5% YoY
Net loss · FY 2024
₹21,090
Net margin -200.7%
EBITDA · FY 2024
-₹21,090
EBITDA margin -200.7%
Authorised capital
₹25 Cr
Registered with MCA
Paid-up capital
₹3.9 Cr
Issued & subscribed
Open charges
₹100 Cr
Satisfied ₹7.75 Cr
Company age
23 yrs
Est. 2003
Directors on board
3
As per MCA filings

About Arch Life Sciences Limited

Data last updated:

Arch Life Sciences Limited is a public limited company based in Hyderabad, Telangana, India, a subsidiary of Arch Pharmalabs Limited. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 15 December 2003 and has been in existence for over 23 years.

The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24239TG2003PLC042232. The company has 2 GST registrations on record, none of which is active.

The company has an authorised share capital of ₹25 Cr and a paid-up capital of ₹3.9 Cr. It was formerly known as Sibra Pharmaceuticals Limited. It is led by directors including Ajit Annu Kamath and Rajendra Padmanabhan Kaimal.

Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at D.No. 8 – 2 – 684/J/8/A Bhavani Nagar Road No.12 Banjara Hills Hyderabad, Telangana, India – 500034.

As per the financials filed for FY 2024, the company reported a revenue of ₹10,510, a growth of 5% compared to the previous year. For the same year it recorded a net loss of ₹21,090 (net margin -200.7%) and EBITDA of -₹21,090 (EBITDA margin -200.7%). Revenue has grown at a compounded annual rate (CAGR) of 6% over five years.

As per MCA filings, the company has open charges of ₹100 Cr and satisfied charges of ₹7.75 Cr on record.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website archpharmalabs.com.

Company details

CIN U24239TG2003PLC042232
Registration Number 042232
Incorporation Date 15 December 2003
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Parent Company Arch Pharmalabs Limited
Compliance Status Active Compliant

CIN history

Arch Life Sciences has one previous CIN (Corporate Identification Number): U24239AP2003PLC042232. The current CIN is U24239TG2003PLC042232, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
U24239TG2003PLC042232Current
U24239AP2003PLC042232Previous

Contact details

Arch Life Sciences Limited's registered office is in Hyderabad, Telangana. Its website is archpharmalabs.com. Its e-mail address is in the company report.

  • Email
  • Registered Address
    D.No. 8 – 2 – 684/J/8/A Bhavani Nagar Road No.12 Banjara Hills Hyderabad, Telangana, India – 500034
  • Industry
    Pharma, Pharmaceutical Retailers & Distributors

To see the full contact details of Arch Life Sciences Limited, buy the company report.

Comprehensive company report
Arch Life Sciences Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Financials of Arch Life Sciences Limited

FY 2024 filings available

Arch Life Sciences Limited reported revenue of ₹10,510 (up 5% YoY) for FY 2024.

Revenue · FY 2024
₹10,510 ▲ 5%
Net loss · FY 2024
₹21,090 margin -200.7%
EBITDA · FY 2024
-₹21,090 margin -200.7%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 5%
5 years · compounded
▲ 6%
EBITDA CAGR growth
1 year
▼ 32%
3 years · compounded
▲ 22%
5 years · compounded
▲ 30%

Revenue has grown at a compounded annual rate (CAGR) of 6% over five years, including 5% growth in the latest year. EBITDA fell 32% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA-₹21,090
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹21,090
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profitability
EBITDA Margin-200.7%
Net Profit Margin-200.7%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Arch Life Sciences Limited, buy the company report.

Board of directors of Arch Life Sciences Limited

Arch Life Sciences has 3 current directors and 7 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Ajit Annu KamathDirector02 Apr 200719 Years 7 MonthsCurrent
Rajendra Padmanabhan KaimalDirector02 Apr 200719 Years 7 MonthsCurrent
Chetan Ajitkumar ShahDirector28 Oct 20179 Years 0 MonthsCurrent

Peer comparison

Arch Life Sciences Limited is compared with the 10 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Prabhu Nutriproducts & Beverages Private Limited₹11,850 (FY 2025)-4.0%Pune, Maharashtra, India
Hemaya Agro Solutions Private Limited₹11,700 (FY 2022)Varkala, Kerala, India
Prestar Exports Private Limited₹11,455 (FY 2016)New Delhi, Delhi, India
Flankers Biotech Private Limited₹10,695 (FY 2025)44.0%Ranchi, Jharkhand, India
Pink India Life Sciences Limited₹10,583 (FY 2018)-99.0%Chennai, Tamil Nadu, India
Arch Life Sciences Limitedthis company₹10,510 (FY 2024)-₹21,090-200.7%5.0%Hyderabad, Telangana, India
Healthcare Pharma Trading Private Limited₹10,350 (FY 2023)Shimla, Himachal Pradesh, India
Hope Remedies Private Limited₹10,061 (FY 2024)7.0%Roorkee, Uttarakhand, India
Avanta Lifesciences Private Limited₹10,000 (FY 2023)Ahmedabad, Gujarat, India
DPB Antibiotics Private Limited₹10,000 (FY 2024)-100.0%Chandigarh, India
Hazun Un Package Praivate Limited₹10,000 (FY 2025)-8.0%Mumbai, Maharashtra, India

To see the full peer comparison of Arch Life Sciences Limited, buy the company report.

Auditor

Arch Life Sciences Limited is audited by Neha C Shah & Associates for the financial year 2023.

Auditor firmFinancial yearFirm registration number
Neha C Shah & AssociatesFY 2023138596

Shareholding

The shareholding of Arch Life Sciences Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2023FY 2021FY 2020FY 2019FY 2018
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Arch Life Sciences Limited, buy the company report.

Charges & borrowings

Open charges
₹100 Cr
Satisfied charges
₹7.75 Cr
Breakdown by lending institutions
State Bank of India₹57.00 Cr
State Bank of Patiala₹27.75 Cr
Indusind Bank Ltd.₹15.25 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
11 Nov 200810136147State Bank of India₹57 CrOpen
01 Mar 200810109603Indusind Bank Ltd.₹15.25 CrOpen
01 Mar 200810109850State Bank of Patiala₹27.75 CrOpen
29 Sep 200490130561Uco Bank₹7.75 CrSatisfied

To see the full charge records of Arch Life Sciences Limited, buy the company report.

Total charge records: 4 View all charges

MSME payment delays

No delayed payments to MSME suppliers are on our record for Arch Life Sciences Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Arch Life Sciences has 2 GST registrations on record, and all of them have been cancelled or are inactive. Only active GST numbers are listed on this page.

Total GSTINs
2
Cancelled / inactive
2

To see the full GST registrations and return filing status of Arch Life Sciences Limited, buy the company report.

Recent activity

Arch Life Sciences Limited has 10 board changes on record since 2007: 3 appointments and 7 cessations. The latest: Kamini Dharmesh Kapadia ceased to be Director on 29 Mar 2019.

AGM
Arch Life Sciences Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Arch Life Sciences Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad.
Ceased
Kamini Dharmesh Kapadia ceased to be Director.
Ceased
Manoor Sayed Husain Sayed ceased to be Additional Director.
Ceased
Sajid Ali Asad Ali Khan ceased to be Additional Director.
Appointed
Chetan Ajitkumar Shah was appointed as Director.
Ceased
Manoj Tejraj Jain ceased to be Director.
Charges
A charge with State Bank Of India of Rs. 57.00 Cr registered on 11 Nov 2008 with Charge ID 10136147 was modified on 30 May 2009.
Ceased
Sivarama Prasad Manne ceased to be Director.
Charges
A charge with State Bank Of India amounted to Rs. 57.00 Cr with Charge ID 10136147 was registered on 11 Nov 2008.
Ceased
Sambasiva Rao Venigalla ceased to be Director.
Charges
A charge with Indusind Bank Ltd. amounted to Rs. 15.25 Cr with Charge ID 10109603 was registered on 01 Mar 2008.

7 earlier events are in the company report.

Frequently asked questions

Arch Life Sciences is an active public limited company based in Hyderabad, Telangana, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 15 December 2003 (23+ years old) and is registered under CIN U24239TG2003PLC042232.

Arch Life Sciences has 3 current directors:

The latest financial statements of Arch Life Sciences on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.

No. Arch Life Sciences has 2 GST registrations on record and all of them are cancelled or inactive.

The CIN (Corporate Identification Number) of Arch Life Sciences is U24239TG2003PLC042232. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Arch Life Sciences was incorporated on 15 December 2003, making it 23+ years old. It is registered with the Registrar of Companies, Hyderabad.

The peers of Arch Life Sciences by revenue are Prabhu Nutriproducts & Beverages Private Limited, Hemaya Agro Solutions Private Limited, Prestar Exports Private Limited, Flankers Biotech Private Limited, Pink India Life Sciences Limited and 5 more, all in the Pharma industry (Pharma Retail and Distribution).

Kamini Dharmesh Kapadia ceased to be Director on 29 Mar 2019. Manoor Sayed Husain Sayed ceased to be Additional Director on 29 Mar 2019. Sajid Ali Asad Ali Khan ceased to be Additional Director on 29 Mar 2019. Arch Life Sciences has 10 board changes on record in total.

Arch Life Sciences can be reached through the website archpharmalabs.com. Its registered office is in Hyderabad, Telangana, India.

The registered office of Arch Life Sciences is at D.No. 8 – 2 – 684J8A Bhavani Nagar Road No.12 Banjara Hills Hyderabad, Telangana, India – 500034.

Arch Life Sciences operates in the pharma industry, in the pharmaceutical retailers and distributors segment.